Calumet (NASDAQ:CLMT) Surprises With Strong Q2 CY2026

Calumet (NASDAQ:CLMT) reported Q2 CY2026 results. Revenue rose 40.8% year on year to $1.45 billion, beating Wall Street estimates by 32% (according to the article). Adjusted EBITDA exceeded consensus by 78.2%, with margin rising to 12.1%. Free cash flow was $99.35 million, turning positive after a year-ago loss.

Original reporting
Published Aug 7, 2026, 12:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 12:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Calumet (NASDAQ:CLMT) Surprises With Strong Q2 CY2026 — source image
Decision brief

The 30-second read

$CLMTBullishMed
01

Why it matters

The immediate trading relevance is the earnings surprise (revenue and adjusted EBITDA beats) and the margin expansion, while the longer-term risk is cash generation sensitivity to crude prices and prior cash burn.

02

Market read

A company-specific earnings beat can drive short-term repricing, but the article’s emphasis on cash-flow volatility suggests traders should watch for confirmation beyond EBITDA.

03

What to watch

The article notes elevated free-cash-flow volatility versus WTI (14.4) and negative average free-cash-flow margin over five years, which can dominate valuation even after an earnings beat.

Relevance 7/10Novelty 6/10Timing: reported Q2 CY2026 results today, with stock noted flat at $42.18 immediately after

Background

Calumet is a specialty products refiner, and the piece frames its Q2 performance using revenue growth, adjusted EBITDA margins, and free cash flow quality.

Company-level read

Ticker impact

$CLMTBullishMedium confidence
Context

Calumet reported Q2 CY2026 revenue up 40.8% to $1.45B and an adjusted EBITDA beat versus consensus, signaling stronger operating leverage.

Expected impact

Near-term upside bias versus expectations, with follow-through dependent on whether cash generation stabilizes.

Evidence & confidence

The article provides concrete earnings metrics (revenue, adjusted EBITDA, margins) and also flags cash burn history and higher sensitivity to WTI, which can cap the rally.

Market effects

Highlights that specialty refiners can show operating leverage in favorable commodity conditions, but cash-flow quality may diverge from EBITDA.

No specific regional demand or policy drivers cited.

No direct global macro or cross-border transaction details provided.

Counterpoint

The EBITDA beat may not translate into durable shareholder value if free cash flow stays negative and remains highly sensitive to WTI swings.

Key entities

  • Calumet

    Reported Q2 CY2026 revenue growth and adjusted EBITDA above consensus, with free cash flow turning positive after a year-ago negative quarter.

Related articles

$CLMTMed

Why Calumet Stock Was a Major Winner on Wednesday

Calumet (CLMT) shares rose more than 4% after the company said two wholly owned subsidiaries will redeem $100 million of senior notes due 2028, paying about 102.4% of par. Calumet also noted it reduced borrowings on its revolving credit facility in Q2, as part of a deleveraging plan.

$ATMUMedAI 8/10

Atmus Filtration: Q2 Earnings Snapshot

Atmus Filtration Technologies (ATMU) reported Q2 net income of $63.9M, or 78 cents per share, and adjusted EPS of 82 cents, above Zacks’ three-analyst average of 79 cents. Revenue was $527.9M. For FY, the company forecast EPS of $2.85 to $3 and revenue of $1.98B to $2.03B.

$WENHighAI 9/10

Why is Wendy’s stock sliding today?

Wendy’s (WEN) shares fell 3.4% pre-open after a mixed Q2 report. Adjusted EPS was $0.18 vs $0.17 and revenue $570.6M vs $545.26M, but the company withdrew its full 2026 outlook and cut its quarterly dividend from $0.14 to $0.07. Same-restaurant sales fell 7.0% and adjusted EBITDA declined 15.4% YoY.

$TGMed

TREDEGAR CORP (TG): Results of Operations and Financial Condition

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 tg-20260630xearningsrelease.htm EX-99 Document TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS • Increased second quarter 2026 results, with net income from continuing operations of $6.0 million, or $0.17 per diluted share, for the second quarter of 2026 compared to $1.8 mil